Quince Therapeutics, Inc. (QNCX)
1.35
-0.01
(-0.74%)
USD |
NASDAQ |
Apr 24, 16:00
1.33
-0.02
(-1.48%)
After-Hours: 20:00
Quince Therapeutics Shareholders Equity (Quarterly) : -35.71M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 1.131B |
| Ocular Therapeutix, Inc. | 654.31M |
| Gossamer Bio, Inc. | -122.76M |
| Ernexa Therapeutics, Inc. | 2.401M |
| Acurx Pharmaceuticals, Inc. | 5.269M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.63M |
| Total Liabilities (Quarterly) | 129.35M |
| Debt to Equity Ratio | -0.5172 |
| Current Ratio | 0.5297 |
| Net Debt Paydown Yield | -0.32% |